For years, the wellness industry has sold India a simple promise: take the supplement, follow the diet, drink the detox, and you’ll feel better.
Yet for millions of consumers, the reality looks very different.
People are eating healthier, tracking calories, taking probiotics, prioritising fitness, and still struggling with bloating, fatigue, acne, poor sleep, low immunity, or persistent digestive discomfort.
Increasingly, consumers are beginning to ask a more uncomfortable question: what if generic wellness advice simply doesn’t work for everyone?
That question sits at the heart of Sova.
About Sova
Founded by Tanveer Singh and Max Kushnir, the startup is building in one of healthcare’s fastest-evolving spaces: precision wellness powered by gut microbiome science.
But unlike many wellness brands focused on selling supplements first, Sova’s approach starts somewhere else entirely: data.
The company believes one of the biggest flaws in modern wellness is that most interventions remain fundamentally one-size-fits-all. Two people with similar symptoms may have completely different underlying biological causes, yet are often prescribed identical diets, probiotics, or supplements.
Sova’s answer is to personalize healthcare at the microbiome level.
Sova’s Gut Microbiome Test
At the centre of Sova’s platform is an at-home Gut Microbiome Test that analyses an individual’s gut bacteria composition and maps potential imbalances linked to digestion, metabolism, immunity, energy, and broader lifestyle symptoms. Based on this analysis, users receive personalized nutrition guidance and custom probiotic formulations tailored specifically to their gut profile.
The company’s flagship offering, Sova X, takes this personalization further.
Unlike traditional probiotics manufactured in massive uniform batches, Sova says every formulation is created individually based on microbiome analysis and user-specific deficiencies.
The company describes it as Asia’s first custom-made probiotic blend, designed around the idea that supplements should adapt to the body, rather than the body adapting to generic supplements.
The founding of Sova
The idea for Sova emerged through the founders’ earlier experiences in the gut health space.
Before launching the company, the founders experimented with a prebiotic beverage venture. But they quickly realized a larger problem: even scientifically sound wellness products often failed because consumers themselves were biologically different.
That insight became the foundation for Sova’s larger vision: India did not simply need another wellness brand. It needed a more personalized approach to preventive healthcare.
The timing for that shift appears increasingly relevant. Over the last few years, preventive healthcare adoption has accelerated across urban India.
Consumers are becoming more proactive about long-term wellness, diagnostics, and lifestyle-linked health risks. Conversations around longevity, metabolism, inflammation, sleep quality, and gut health have also become significantly more mainstream.
Globally too, advancements in microbiome science are reshaping how healthcare systems understand the connection between the gut and overall wellbeing.
Researchers are linking gut bacteria not only to digestion, but also to immunity, mood regulation, energy levels, inflammation, skin health, and cognitive function
Gut health and India
For Indian consumers, however, gut health still remains a confusing category.
The market is crowded with supplements, probiotics, and wellness products making broad claims around digestion and immunity. At the same time, many consumers remain skeptical after trying multiple generic solutions with limited results.
Sova’s strategy appears to focus on addressing the root cause behind consumer health concerns rather than relying on generic wellness solutions.
Across platforms like Instagram, WhatsApp, YouTube, and digital consultations, the company attempts to simplify microbiome science into everyday concerns consumers already experience: why someone feels bloated after meals, why fatigue persists despite healthy eating, or why certain foods trigger discomfort in one person but not another.
Instead of approaching wellness through broad, one-size-fits-all recommendations, the company’s larger focus lies in understanding the underlying biological imbalances driving these symptoms and using microbiome insights to build more personalized interventions.
The company also leans heavily into expert-led communication through nutritionists, microbiome specialists, and clinicians to bridge the gap between science and accessibility.
Beyond gut health into generating evidence
Today, Sova says it has served more than 1,50,000 customers across 390 Indian cities and actively works with individuals dealing with IBS, IBD, and chronic gut-related symptoms through nutrition counseling and microbiome-led interventions.
But beyond personalized supplements, one of the company’s larger ambitions lies in the data itself.
Every microbiome test contributes to a growing database of gut health insights across Indian populations. Over time, Sova says this data is helping identify broader microbiome patterns linked to digestive disorders, inflammation, metabolic dysfunction, and lifestyle-related conditions.
The larger opportunity extends beyond probiotics alone.
Globally, healthcare systems are steadily moving toward more preventive and data-driven approaches, where biological testing can help identify underlying imbalances before they evolve into chronic conditions.
At-home stool-based microbiome tests are emerging not only as tools to better understand existing digestive symptoms, but also as early-warning systems that can flag potential risks linked to inflammation, metabolic dysfunction, immunity, and long-term health outcomes.
Companies operating in microbiome science believe gut health analytics could eventually become part of that infrastructure.
Looking forward
The broader direction of healthcare appears increasingly clear.
Consumers no longer want generic wellness promises. They want specificity. They want measurable insight. They want healthcare that feels tailored rather than standardized.
And increasingly, startups like Sova are betting that the future of wellness may not lie in selling the same solution to everyone, but in understanding why no two bodies are truly the same.
